1. Home
  2. CPIX

as of 12-02-2025 3:15pm EST

$2.21
+$0.05
+2.31%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Chart Type:
Time Range:
Founded: 1999 Country:
United States
United States
Employees: N/A City: NASHVILLE,
Market Cap: 51.5M IPO Year: 2009
Target Price: N/A AVG Volume (30 days): 74.0K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.23 EPS Growth: N/A
52 Week Low/High: $1.09 - $7.25 Next Earning Date: 11-04-2025
Revenue: $41,278,349 Revenue Growth: 12.21%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Latest Cumberland Pharmaceuticals Inc. News

CPIX Breaking Stock News: Dive into CPIX Ticker-Specific Updates for Smart Investing

All CPIX News

Share on Social Networks: